UY31704A - Compuesto heterociclico fusionado - Google Patents

Compuesto heterociclico fusionado

Info

Publication number
UY31704A
UY31704A UY0001031704A UY31704A UY31704A UY 31704 A UY31704 A UY 31704A UY 0001031704 A UY0001031704 A UY 0001031704A UY 31704 A UY31704 A UY 31704A UY 31704 A UY31704 A UY 31704A
Authority
UY
Uruguay
Prior art keywords
fused
compound
heterociclic
represented
formula
Prior art date
Application number
UY0001031704A
Other languages
English (en)
Inventor
Ishikawa Tomoyasu
Kawakita Youichi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of UY31704A publication Critical patent/UY31704A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

La presente invención provee un compuesto heterocíclico fusionado que tiene una acción inhibidora de tirosina quinasa que está representada por la fórmula
UY0001031704A 2008-03-12 2009-03-11 Compuesto heterociclico fusionado UY31704A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008063363 2008-03-12

Publications (1)

Publication Number Publication Date
UY31704A true UY31704A (es) 2009-11-10

Family

ID=41063727

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031704A UY31704A (es) 2008-03-12 2009-03-11 Compuesto heterociclico fusionado

Country Status (8)

Country Link
US (1) US20090233937A1 (es)
EP (1) EP2253633A4 (es)
JP (1) JPWO2009113560A1 (es)
AR (1) AR070874A1 (es)
PE (1) PE20091580A1 (es)
TW (1) TW200944528A (es)
UY (1) UY31704A (es)
WO (1) WO2009113560A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2389731C2 (ru) * 2004-06-02 2010-05-20 Такеда Фармасьютикал Компани Лимитед Конденсированное гетероциклическое соединение
WO2011040212A1 (en) 2009-10-01 2011-04-07 Takeda Pharmaceutical Company Limited Therapeutic agent for brain tumor
ES2531465T3 (es) 2010-12-23 2015-03-16 Sanofi Derivados de pirimidinona, su preparación y su utilización farmacéutica
KR20130015400A (ko) 2011-08-03 2013-02-14 삼성디스플레이 주식회사 헤테로고리 화합물 및 이를 포함하는 유기 전계 발광 소자
KR101930848B1 (ko) 2011-08-11 2018-12-20 삼성디스플레이 주식회사 헤테로고리 화합물 및 이를 포함하는 유기 전계 발광 소자
KR101971198B1 (ko) 2011-10-19 2019-04-23 삼성디스플레이 주식회사 헤테로시클릭 화합물, 이를 포함하는 유기 발광 소자 및 평판 표시 장치
CN105814057B (zh) * 2013-07-31 2019-05-03 默克专利有限公司 用作btk抑制剂的嘧啶、吡啶和吡嗪及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US6395733B1 (en) * 1995-06-07 2002-05-28 Pfizer Inc Heterocyclic ring-fused pyrimidine derivatives
DK0831829T3 (da) 1995-06-07 2003-12-15 Pfizer Heterocykliske, ringkondenserede pyrimidinderivater
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
ID19430A (id) 1996-07-13 1998-07-09 Glaxo Group Ltd Senyawa senyawa heterosiklik
AU3461797A (en) 1996-07-19 1998-02-10 Takeda Chemical Industries Ltd. Fas ligand-like protein, its production and use
KR20000057228A (ko) 1996-11-27 2000-09-15 디. 제이. 우드, 스피겔 알렌 제이 축합된 비사이클릭 피리미딘 유도체
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
YU95102A (sh) 2000-06-22 2005-11-28 Pfizer Products Inc. Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija
CZ299561B6 (cs) 2000-06-30 2008-09-03 Glaxo Group Limited Chinazolinaminový derivát a farmaceutický prostredek
WO2003031442A1 (fr) 2001-10-05 2003-04-17 Takeda Chemical Industries, Ltd. Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation
WO2003049740A1 (en) 2001-12-12 2003-06-19 Pfizer Products Inc. Quinazoline derivatives for the treatment of abnormal cell growth
UA75482C2 (en) 2001-12-12 2006-04-17 Pfizer Prod Inc Salts of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methylpyridine-3-yloxy)phenylamino]quinozaline -6-yl}alyl)acetamide, a method for the preparation and use thereof for the treatment of cancer
AU2002357193A1 (en) 2001-12-19 2003-07-09 Smithkline Beecham Corporation Thienopyrimidine compounds as protein tyrosine kinase inhibitors
RU2389731C2 (ru) 2004-06-02 2010-05-20 Такеда Фармасьютикал Компани Лимитед Конденсированное гетероциклическое соединение
TW200730527A (en) * 2005-12-02 2007-08-16 Takeda Pharmaceuticals Co Fused heterocyclic compound
JP4504337B2 (ja) 2006-09-04 2010-07-14 株式会社御池鐵工所 ガス化炉及びガス化炉システム
CN101611041A (zh) * 2006-12-12 2009-12-23 武田药品工业株式会社 稠合杂环化合物

Also Published As

Publication number Publication date
EP2253633A1 (en) 2010-11-24
JPWO2009113560A1 (ja) 2011-07-21
US20090233937A1 (en) 2009-09-17
EP2253633A4 (en) 2012-02-29
AR070874A1 (es) 2010-05-12
PE20091580A1 (es) 2009-11-05
WO2009113560A1 (ja) 2009-09-17
TW200944528A (en) 2009-11-01

Similar Documents

Publication Publication Date Title
CY1119218T1 (el) Αναστολεις διυδροπυριδοφθαλαζινονης της πολυμερασης της πολυαδενοσφωσφορικης ριβοζης (parp)
MA32938B1 (fr) Composes organiques
CY1112102T1 (el) Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
UA107796C2 (en) Tetracyclic compound
DK2364308T3 (da) Pyrazinforbindelser som inhibitorer af Phosphodiesterase 10
BRPI1010795A2 (pt) compostos antivirais
DK3354650T3 (da) Forbindelser der er nyttige som inhibitorer af ATR-kinase
BRPI0922880A2 (pt) compostos inibidores de quinase
DK1761520T3 (da) Kinaseinhibitorer
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
CR20120333A (es) Isoquinolinonas y quinazolinonas substituidas.
CR20120295A (es) Triazolopiridinas
ATE479673T1 (de) Hemmer der neubildung menschlicher immundefekt- viren
UY31704A (es) Compuesto heterociclico fusionado
CR20110169A (es) Compuestos de pirrol
CL2012000315A1 (es) Compuestos derivados de heterociclos; y proceso de aplicacion de dichos compuestos.
EA200900945A1 (ru) Новый способ синтеза агомелатина
CU20090017A7 (es) Peptidomimeticos de smac utiles como inhibidores de proteinas de apoptosis (iap)
CR20120297A (es) Espironucleósidos uracílicos oxetánicos
UY31688A1 (es) Plaguicidas
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20110432A (es) Pirimidinas fusionadas
EA201070182A1 (ru) Алкилсульфонилзамещённые тиазолидные соединения
DOP2005000010A (es) Inhibidores de quinasa

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20100604